Literature DB >> 17961008

Surgical management of the tethered spinal cord--walking the fine line.

James M Drake1.   

Abstract

The tethered spinal cord is a fascinating yet controversial condition seen frequently in neurosurgical practice. Treatment decision making is made difficult by the variety of lesions and clinical presentations comprised by this condition and the absence of high-quality clinical outcome data to provide guidance. Clinical presentations may be divided into four general categories or typical scenarios: 1) significant dysraphic abnormality, clear clinical deterioration; 2) significant dysraphic abnormality, normal examination results or stable deficit; 3) incidentally discovered abnormality, other problem; and 4) tethered spinal cord symptomatology, normal imaging. The author provides case examples to illustrate potential treatment approaches and suggests balancing the risks and benefits for each general category. Clearer diagnostic and treatment strategies for the tethered spinal cord will only result from high-quality clinical and basic research. Until the results of such research are available, surgeons should endeavor to maximize benefit and reduce risk for patients who may have a tethered spinal cord, walking the fine line between over- and undertreatment.

Entities:  

Mesh:

Year:  2007        PMID: 17961008     DOI: 10.3171/FOC-07/08/E4

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  11 in total

Review 1.  [Spina bifida].

Authors:  R Mühl-Benninghaus
Journal:  Radiologe       Date:  2018-07       Impact factor: 0.635

Review 2.  Systematic Review of Urologic Outcomes from Tethered Cord Release in Occult Spinal Dysraphism in Children.

Authors:  Jeffrey T White; Derek C Samples; Juan C Prieto; Izabela Tarasiewicz
Journal:  Curr Urol Rep       Date:  2015-11       Impact factor: 3.092

3.  Prognosis of surgical treatment of the tethered cord syndrome in children.

Authors:  Kirill Sysoev; Arsen Tadevosyan; Konstantin Samochernykh; William Khachatryan
Journal:  Childs Nerv Syst       Date:  2017-10-24       Impact factor: 1.475

Review 4.  Conservative and surgical treatment of pediatric asymptomatic lumbosacral lipoma: a meta-analysis.

Authors:  Yang Xiong; Liu Yang; Wang Zhen; Dong Fangyong; Wan Feng; Lei Ting
Journal:  Neurosurg Rev       Date:  2016-10-28       Impact factor: 3.042

5.  Variation in Outcome in Tethered Cord Syndrome.

Authors:  Noorulain Iqbal; Mohsin Qadeer; Salman Yousuf Sharif
Journal:  Asian Spine J       Date:  2016-08-16

6.  Children with tethered cord syndrome of different etiology benefit from microsurgery-a single institution experience.

Authors:  Pantelis Stavrinou; Mathias Kunz; Markus Lehner; Alfred Heger; Wolfgang Müller-Felber; Joerg-Christian Tonn; Aurelia Peraud
Journal:  Childs Nerv Syst       Date:  2011-01-06       Impact factor: 1.475

7.  Symptomatic retethering of the spinal cord in postoperative lipomyelomeningocele patients: a meta-analysis.

Authors:  Dylan J Goodrich; Dipen Patel; Marios Loukas; R Shane Tubbs; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2015-08-07       Impact factor: 1.475

8.  Coincidence of Tethered Cord, Filum Terminale Lipoma, and Sacral Dural Arteriovenous Fistula: Report of Two Cases and a Literature Review.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Paulina Juszyńska; Michał Zawadzki; Bogdan Ciszek; Mariusz Głowacki; Andrzej Marchel
Journal:  Front Neurol       Date:  2018-09-27       Impact factor: 4.003

9.  Radiographic characteristics in congenital scoliosis associated with split cord malformation: a retrospective study of 266 surgical cases.

Authors:  Fan Feng; Haining Tan; Xingye Li; Chong Chen; Zheng Li; Jianguo Zhang; Jianxiong Shen
Journal:  BMC Musculoskelet Disord       Date:  2017-10-23       Impact factor: 2.362

10.  Long-term evaluation of intraoperative neurophysiological monitoring-assisted tethered cord surgery.

Authors:  S E Dulfer; G Drost; F Lange; H L Journee; F H Wapstra; E W Hoving
Journal:  Childs Nerv Syst       Date:  2017-07-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.